All in one. No code.

Research
Study Hub

We make secure data collection, management and analysis effortless — so you can focus on what really matters: driving research, improving outcomes and making a global impact.

Who are we?

Indacas is a new platform currently in development by The Newcastle RSE Team. We are part of Newcastle University.

Indacas is already powering 7 university research studies and serving over 7,000 study participants and patients from across the world.

We believe that the current tools and systems for capturing study data are archaic. Indacas is designed to revolutionise the way researchers work and improve systems for sharing knowledge.

We want your input to make Indacas the best platform it can be - putting control back into the hands of researchers and their teams. Please get in touch if you think you have the expertise required to shape this platform.

Join the waiting list

Subscribe to our newsletter to receive the latest updates and insights from Indacas

Sign up now and receive a free month added to your subscription plan when we launch

Built by researchers,

for researchers

Developed by researchers, our platform empowers you design and manage fully customised studies. No specialist coding, certifications or additional IT support required.

Secure

Protect sensitive data with encryption, role-based access and full audit trails.

Collaborative

Create studies within organisations and invite peers to help manage your studies.

Flexible

No coding or training required. Build your surveys with all the features you prefer - hassle free.

Compliant

Designed to support regulatory and institutional requirements with consent flows, retention controls and audit-ready exports.

Indacas is unlocking research

Founded in 2025, we’re immensely proud of the groundbreaking studies that are already being powered by Indacas. These studies are engaging thousands of participants to accelerate medical breakthroughs uncover new insights and advance global scientific goals. Read more below:
September 23, 2025

COLO-SPEED

Colospeed logo
by Colospeed
Our aim is to stop people dying of bowel cancer. Bowel cancer, also called colorectal cancer (CRC), is the fourth most common cancer and the second most common cancer death in the UK. COLO-SPEED (Colo...
September 23, 2025

DM Patient Registry

Colospeed logo
by The UK Myotonic Dystrophy Patient Registry
For the treatment of Myotonic Dystrophy, promising new therapeutic strategies are currently being developed which need to be tested in clinical trials/research studies. This registry will make the rec...
September 23, 2025

Adult SMA Reach

Adult SMA Reach logo
by Adult SMA Reach
Adult SMA REACH (Research and Clinical Hub) is a data collection study aiming to gain a better understanding of the impact of standards of care and new treatments on the natural history of Spinal Musc...
September 23, 2025

FSHD Patient Registry

FSHD logo
by The UK FSHD Patient Registry
This registry is for patients living in the United Kingdom who are affected by Facioscapulohumeral dystrophy (FSHD type 1 or 2), with no age restrictions. This registry is primarily designed to collec...
September 23, 2025

DMD Hub

DMD Hub logo
by The DMD Hub
The DMD Hub Site Feasibility and Clinical Trial Database is part of the DMD Hub tools and services offer, allowing colleagues at DMD Hub clinical trial sites to provide and store information about the...
September 23, 2025

UK SMA Patient Registry

UK SMA Patient Registry logo
by UK SMA Patient Registry
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder. The small number of individuals affected by SMA presents a challenge to the study of the disorder and the understanding of the impact of...

Get in touch

Do you have a question we haven't answered? Get in touch and we'll get back to you as soon as possible.